Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
dasatinib
.
Show all posts
Showing posts with label
dasatinib
.
Show all posts
Friday, April 10, 2020
Dasatinib Tops Imatinib for Ph+ Acute Lymphoblastic Leukemia
›
In continuation of my update on dasatinib and imatinib Dasatinib is associated with improved survival for pediatric patients with...
Wednesday, December 20, 2017
FDA Expands Approval of Sprycel (dasatinib) to Include Treatment of Children with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
›
In continuation of my update on Sprycel ( dasatinib ) Bristol-Myers Squibb Company (NYSE:BMY) announced the U.S. Food and Drug A...
Thursday, January 19, 2017
Long-term dasatinib findings support first-line use in CML
›
In continuation of my update on dasatinib Final DASISION study findings confirm dasatinib to be an effective, long-term treatment for ...
›
Home
View web version